A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19.

Since human angiotensin-converting enzyme 2 (ACE2) serves as a primary receptor for SARS-CoV-2, characterizing ACE2 regions that allow SARS-CoV-2 to enter human cells is essential for designing peptide-based antiviral blockers and elucidating the pathogenesis of the virus. We identified and synthesized a 25-mer mimetic peptide (encompassing positions 22-46 of the ACE2 alpha-helix α1) implicated in the S1 receptor-binding domain (RBD)-ACE2 interface. The mimetic (wild-type, WT) ACE2 peptide significantly inhibited SARS-CoV-2 infection of human pulmonary Calu-3 cells in vitro.

Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi survey.

Background And Objective: Severe hypoglycaemia (SH) imposes a significant burden for people with diabetes (PwD), their caregivers (CGs), and the healthcare system. The study aimed to identify barriers and solutions in the management of SH in PwD in Spain, gathering consensus from physicians and nurses.

Material And Methods: Expert opinion from physicians and nurses who manage PwD was collected via a 2-round online Delphi method.

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia.

Background: Mechanisms driving the progression of chronic lymphocytic leukemia (CLL) from its early stages are not fully understood. The acquisition of molecular changes at the time of progression has been observed in a small fraction of patients, suggesting that CLL progression is not mainly driven by dynamic clonal evolution. In order to shed light on mechanisms that lead to CLL progression, we investigated longitudinal changes in both the genetic and immunological scenarios.

Atherosclerosis and Coenzyme Q.

Atherosclerosis is the most common cause of cardiac deaths worldwide. Classically, atherosclerosis has been explained as a simple arterial lipid deposition with concomitant loss of vascular elasticity. Eventually, this condition can lead to consequent blood flow reduction through the affected vessel.

Preconcentration speciation method for mercury compounds in water samples using solid phase extraction followed by reversed phase high performance liquid chromatography.

A simple and rapid method for in situ preconcentration of inorganic and organic mercury compounds in water samples, based on solid phase extraction using dithizone immobilised on a reversed-phase C18 cartridge, has been developed. The adsorbed complexes were stable on the cartridge for at least 2 weeks. The speciation analysis of methylmercury (MeHg), phenylmercury (PhHg) and inorganic mercury (Hg (II)) were done by reversed-phase high performance liquid chromatography.